Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00255840Not ApplicableCompleted

Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities

Role: lead

NCT00096681Completed

Prevalence of HIV and Tuberculosis in Masiphumelele Township, Cape Town, South Africa

Role: lead

NCT00099658Not ApplicableUnknown

Safety of and Immune Response to a Pneumococcal Vaccine (PncCV) in HIV Infected and Uninfected Children

Role: lead

NCT00346476Completed

Characteristics and Prevalence of Tuberculosis and HIV in Masiphumelele Township, Cape Town, South Africa

Role: lead

All 4 trials loaded